Parathyroid Hormone (rDNA) ( DrugBank: Parathyroid hormone )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
235	副甲状腺機能低下症	2

235. 副甲状腺機能低下症

---

臨床試験数 : 88 /  薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-003108-22-GB (EUCTR)	08/12/2015	26/10/2015	Study on parathyroid hormone for use in hypoparathyroidism in children 12 to less than 18 years old.	An Open-label, Single-dose Study to Determine the Pharmacokinetic/Pharmacodynamic Profile of Parathyroid Hormone (rDNA) Administered Subcutaneously at a Dose of50 µg in Subjects with Hypoparathyroidism Who Are 12 to LessThan 18 Years of Age	Chronic hypoparathyroidism;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Parathyroid Hormone (rDNA) Product Code: NPSP 558 INN or Proposed INN: INN Parathyroid Hormone (1-84) human Other descriptive name: Parathyroid Hormone (1-84) Human Recombinant	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	10	Phase 1	United Kingdom
2	EUCTR2008-000606-36-DK (EUCTR)	07/04/2008	25/03/2008	Treatment of hypoparathyroidism with subcutaneous PTH (1-84) injections: effects on muscle function and quality of life - HypoPT	Treatment of hypoparathyroidism with subcutaneous PTH (1-84) injections: effects on muscle function and quality of life - HypoPT	Hypoparathyroidism MedDRA version: 9.1;Level: LLT;Classification code 10021041;Term: Hypoparathyroidism	Trade Name: Preotact Product Name: parathyroid hormone (rdna) Product Code: SUB21634 INN or Proposed INN: Parathyroideahormon	Aarhus University Hospital, Dept of Endocrinology and Metabolism C	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 4	Denmark